Folic acid and food fortification: Implications for the primary care practitioner

Nurse Practitioner

Volumn 22, Issue 3, 1997, Pages 105-115

  Tinkle, Mindy ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

CEREAL; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; NEOPLASM; NEURAL TUBE DEFECT; NURSE PRACTITIONER; PRIMARY HEALTH CARE; PUBLIC HEALTH; REVIEW; UNITED STATES;

CEREALS; CORONARY DISEASE; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HUMANS; NEOPLASMS; NEURAL TUBE DEFECTS; NURSE PRACTITIONERS; PRIMARY HEALTH CARE; PUBLIC HEALTH; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0031093072     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/00006205-199703000-00009     Document Type: Article

References (42)

1. U.S. Food and Drug Administration: Food standards: Amendment of standard of identity for enriched grain products to require addition of folic acid. Federal Register 1996;61(44):8761-97.
2. Mine RJ: What practitioners need to know about folic acid. J Am Diet Assoc 1996;86(5):45l-53.
3. Centers for Disease Control: Knowledge and use of folic acid by women of childbearing age-United States, 1995. MMWR 1995;44:716-18.
4. Shaw GM, Lammcr EJ, Wasserman CR, et al: Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptu- ally. Lancet 1995;345:393-96.
5. Boushey CJ, Beresford SA, Omenn GS, et al: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 1995;274(13): 1049-57.
6. Glynn SA, Albanes D: Folate and cancer: a review of the literature. Nutr Cancer 1994;22(2): 101-19.
7. Oakley GP, Erickson JD, Adams MJ: Urgent need to increase folic acid consumption. J Am Med Assoc 1995;274(21):1717-18.
8. Czeizel AE: Folic acid in the prevention of neural tube defects. J Pediatr Gastroenterol Nutr 1995;20(1):4-16.
9. Reider MJ: Prevention of neural tube defects with periconceptual folic acid. Clin Perinatol 1994;21(3):483-503.
10. Czeizel AE, Dudas I: Vitamins to prevent neural-tube defects (Letter to the editor). New Engl J Med 1993;328(22): 1642.
11. Mine J: Folic acid: contemporary clinical perspective. Perspect Appl Nutr 1993; 1(2):3-13.
12. Czeizel AE, Dudas I: Prevention of the first occurrcnce of neural-tube defects by periconceptual vitamin supplementation. New Engl J Med 1992; 327(26):1832-35.
13. Medical Research Council Vitamin Study Research Group: Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338(8760):131-37.
14. Werler MM, Shapiro S, Mitchell AA: Periconceptual folic acid exposure and risk of occurrent neural tube defects. J Am Med Assoc 1993;269(10): 1257-61.
15. Centers for Disease Control: Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR; 41 (RR-14): 1-6.
16. Boushey CJ, Beresford AA, Omenn GS, et al: A quantitative assessment of homocysteine as a risk factor for vascular disease. J Am Med Assoc 1995; 274(13): 1049-57.
17. Brattstrom LE, Israelsson B, Jeppsson JO, et al: Folic acid: an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1988; 48(3):215-21.
18. Ubbink JB, Vermaak WJ, van der Merwe A, et al: Vitamin requirements for the treatment of hyperhomocystenemia in humans. J Nutr 1994; 124(10): 1927-33.
19. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995;345:149-51.
20. Bratlstrotn L: Vitamins as homocysteinc-iowering agents. J Nutr 1996; 126: 1276S-1280S.
21. Butterworth CE, Hatch KD, Macaiuso M, et al: Folate deficiency and cervical dysplasia. J Am Med Assoc 1992; 267(4):528-33.
22. Butterworth CE, Hatch KD, Gore H, et al: Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr 1982;35(1):73-82.
23. Buckley DI, McPherson RS, North CQ, et al: Dietary micronutrients and cervical dysplasia in southwestern American Indian women. Nutr Cancer 1992; 17(2): 179-85.
24. VanEenwyk J, David FG, Colman N: Folate, vitamin C, and cervical intra- epithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1992;1(2):119-24.
25. Giovannucci E, Stampfer MJ, Colditz GA, et al: Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993; 85(11):875-84.
26. Benito E, Cabeza E, Moreno V, et al: Diet and colorectal adenomas: a case- control study in Majorca. Int J Cancer 1993;55(2):213-19.
27. Freudenhcim JL, Graham S, Marshall JR, et al: Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 1991;20(2):368-74.
28. Meyer F, White E: Alcohol and nutrients in relation to colon cancer in mid- dle-aged adults. Am J Epidemiol 1993;138(4):225-36.
29. Benito E, Stiggelbout A, Bosch FX, et al: Nutritional factors in colorectal cancer risk: a case-control study in Majorca. Int J Cancer 1991;49(2): 161-67.
30. Bailey LB: Evaluation of a new recommended dietary allowance for folate. J Am Diet Assoc 1992;92(4):463-71.
31. Willet WC: Folic acid and neural tube defects: can’t we come to closure? Am J Public Health 1992:82(5):666-68.
32. Subar AT, Block G, James LD: Folate intake and food sources in the US population. Am J Clin Nutr 1989;50:508-16.
33. Piyathilake CJ, Macaiuso M, Hine RJ, et al: Local and systemic effects of cigarette smoking on folate and vitamin B12. Am J Clin Nutr 1994;60:559-66.
34. Butterworth CE: Folate status, women’s health, pregnancy outcome, and cancer. J Am Coll Nutr 1993; 12(4):438-41.
35. Yetley EA, Rader JI: Folate fortification of cereal-grain products: FDA policies and actions. Cereal Foods World 1995;40(2):67-72.
36. Crane NT, Wilson DK, Cook A, et al: Evaluating food fortification options: general principles revisited with folic acid. Am J Public Health 1995;85(5):660-66.
37. Cuskelly GJ, McNulty H, Scott JM: Effect of increasing dietary folate on redcell folate: implications for prevention of neural tube defects. Lancei 1996;347:657-59.
38. U.S. Food and Drug Administration: Food labeling: health claims and label statements: folate and neural tube defects. Federal Register 1993;58(197) 53254-53317.
39. Carmel R, Johnson SC: Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic factor antibody in black women. New Engl J Med 1978;2986(12):647-50.
40. Goroll AH, May LA, Mulley AG: Primary Care Medicine, 3rd ed. Philadelphia: J.B. Lippincott, 1995:468-71.
41. Butterworth CE, Tamura T: Folic acid safety and toxicity: a brief review. An J Clin Nutr 1989;50:353-58.
42. Rose, NC, Mennuti, MT: Periconceptual folate supplementation and neura tube defects. Clin Obstet Gynecol 1994;37(3):605-20.